CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $31 | $35 | $35 | $34 |
| % Growth | -10.8% | -1.2% | 2.4% | – |
| Cost of Goods Sold | $9 | $10 | $9 | $8 |
| Gross Profit | $22 | $24 | $23 | $25 |
| % Margin | 70% | 70.5% | 64.9% | 74.5% |
| R&D Expenses | $6 | $5 | $5 | $4 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $10 | $11 | $13 | $14 |
| Sales & Mktg Exp. | $9 | $10 | $12 | $13 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16 | $17 | $18 | $18 |
| Operating Income | $6 | $8 | $8 | $8 |
| % Margin | 18.5% | 22.2% | 21.7% | 22.4% |
| Other Income/Exp. Net | $0 | -$0 | $1 | $1 |
| Pre-Tax Income | $6 | $7 | $9 | $8 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $5 | $6 | $7 | $7 |
| % Margin | 14.9% | 17% | 19.7% | 20.1% |
| EPS | 1.56 | 2 | 2.04 | 1.88 |
| % Growth | -22% | -2% | 8.5% | – |
| EPS Diluted | 1.56 | 2 | 2.04 | 1.88 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $7 | $9 | $9 | $9 |
| % Margin | 22.2% | 24.7% | 24.7% | 27.1% |